News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Akhil Santhosh: Addition of cadonilimab to chemotherapy in advanced cancer of GEJ
hartfordhospital.org
Jan 25, 2025, 06:00

Akhil Santhosh: Addition of cadonilimab to chemotherapy in advanced cancer of GEJ

Akhil Santhosh, a Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“Addition of anti-PD1/CLTLA-4 bispecific antibody cadonilimab to chemotherapy significantly improves PFS and OS in advanced cancer of gastroesophageal junction (GEJ)/stomach: Compassion 15 trial.”

More posts featuring Akhil Santhosh.

Akhil Santhosh antibody cadonilimab cancer chemotherapy gastroesophageal junction OncoDaily Oncology stomach
Special Coverage
Insight
Jan 25, 2025, 06:00
Akhil Santhosh: Addition of cadonilimab to chemotherapy in advanced cancer of GEJ
Blog
Jan 25, 2025, 05:55
Registration is open for the "Maximizing Therapeutic Innovations in Bladder Cancer" Symposium - PVI
Dialogues
Jan 25, 2025, 05:08
Colorectal Cancer in Pediatric Patients: A Rare and Critical Concern
Blog
Jan 25, 2025, 05:06
Danielle Pastor Leads Clinical Trial on ANK-101 Immunotherapy - NCI Center for Cancer Research
Blog
Jan 25, 2025, 05:05
Fumiko Ladd Chino: The next cancer cure is on hold
Insight
Jan 25, 2025, 05:02
HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis
Insight
Jan 25, 2025, 04:58
Al-Ola Abdallah: Myeloma Drug Prices
Dialogues
Jan 25, 2025, 04:54
ASCO24 Updates: Pablo Jiménez-Labaig on Mental Health in Head and Neck Cancer Patients
Insight
Jan 25, 2025, 04:25
New Research to Help GPs Spot Cancer Earlier Using Routine Blood Tests
Insight
Jan 25, 2025, 04:17
Crystal L. Mackall - Candidate for Board of Directors of AACR
Science
Jan 25, 2025, 04:12
Jarushka Naidoo: De-Escalation Strategies With ICIs in NSCLC - Do We Already Have Enough Evidence?
Science
Jan 25, 2025, 04:09
Mohamed Gouda: Selinexor in Combination with Immune Checkpoint Inhibition in Uveal Melanoma